Researchers have identified two forms of estrogen, estradiol and estriol, that may reduce inflammation and protect nerve fibers in progressive multiple sclerosis (MS).
3don MSN
Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis
About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of ...
Tr1X has won an FDA green light for a clinical trial testing TRX319, a cell therapy designed to restore immune balance, for ...
EXTON, Pa., June 26, 2018 /PRNewswire/ -- Largely fueled by Genentech's Ocrevus availability, a paradigm shift has occurred in the US multiple sclerosis (MS) market resulting in increased rates of ...
More than 20 years ago, as Jennifer Digmann focused on completing her coursework and graduating from college, she began experiencing numbness in her hands and feet and eventually double vision. After ...
Zenas Biopharma has acquired global rights to develop BTK inhibitor orelabrutinib to treat progressive forms of multiple ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments ...
Pittsburgh Public Schools is turning to more progressive methods of discipline, after finding that cut and dry methods, like Zero Tolerance, led to too many suspensions. Back in the ‘90s, many schools ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback